Medication info
Zdapragliflozin 10 mg (Empagliflozin)

Zdapragliflozin 10 mg (Empagliflozin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›10mg / 1 tablet
Manufacturer / importer
Youngpoong Pharmaceutical Co., Ltd.
Appearance
Light yellow, round, biconvex film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202102104 · Approved 2021.03.05 · Insurance code 661905650

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes
Who takes it
Adults
Adult dose
The recommended dose of this medication is 10 mg once daily, either as monotherapy or as add-on combination therapy with other blood glucose-lowering agents, such as insulin. If 10 mg of this medication is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medication is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, Section 3. Adverse Reactions). This medication may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take double the dose in one day. No dose adjustment is necessary for patients with mild renal impairment. Treatment with this medication should not be initiated in patients with an estimated glomerular filtration rate (eGFR) below 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medication well but have a persistently estimated glomerular filtration rate below 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose of this medication should be adjusted to or maintained at 10 mg once daily. This medication should be discontinued if the estimated glomerular filtration rate decreases to below 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medication in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medication is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years and older. Initiation of treatment with this medication is not recommended in patients aged 85 years and older, as clinical experience is limited (see Precautions for Use, Section 4. General Precautions)

Ingredients

Manufacturer
Youngpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes

  • Difficulty in blood sugar control
  • inability to control blood sugar
  • type 2 diabetes
View approved original text

This medication assists in controlling blood sugar levels more effectively for adult patients with type 2 diabetes through diet and exercise therapies. It can be used as monotherapy or in combination with metformin or other antidiabetic agents when blood sugar control is difficult. It is especially applied to patients with no prior experience in medication treatment or to those whose blood sugar is not adequately controlled with metformin monotherapy. Additionally, effective blood sugar management is possible with combination therapy with insulin or pioglitazone. Since this medication should be used cautiously for type 2 diabetes patients who have cardiovascular diseases, it is important to follow the guidance of healthcare professionals. Overall, this medication is used to improve blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

The recommended dose of this medication is 10 mg once daily, either as monotherapy or as add-on combination therapy with other blood glucose-lowering agents, such as insulin. If 10 mg of this medication is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medication is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, Section 3. Adverse Reactions). This medication may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take double the dose in one day. No dose adjustment is necessary for patients with mild renal impairment. Treatment with this medication should not be initiated in patients with an estimated glomerular filtration rate (eGFR) below 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medication well but have a persistently estimated glomerular filtration rate below 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose of this medication should be adjusted to or maintained at 10 mg once daily. This medication should be discontinued if the estimated glomerular filtration rate decreases to below 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medication in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medication is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years and older. Initiation of treatment with this medication is not recommended in patients aged 85 years and older, as clinical experience is limited (see Precautions for Use, Section 4. General Precautions)

Precautions

This medication should not be used by certain patients. First, patients who are allergic to this medication's active ingredients or components should not take it. It should also not be used in patients with type 1 diabetes or diabetic ketoacidosis. It is contraindicated in patients with severely impaired kidney function, specifically with a glomerular filtration rate of less than 30 mL/min/1.73m² or those with end-stage kidney disease or who are on dialysis. Moreover, this medication contains lactose; therefore, patients with genetic issues such as lactose intolerance, lactose deficiency, or glucose-galactose malabsorption should not take it. Caution should be exercised when using in patients with slightly impaired kidney function. For patients with a glomerular filtration rate of less than 60 mL/min/1.73m², it is advisable not to initiate treatment with this medication. If a patient tolerates this medication well but continues to have decreasing kidney function, dosage adjustment or discontinuation should be considered. There is no expected efficacy of this medication in patients with end-stage kidney disease or those on dialysis. Regular monitoring of kidney function before and during medication use is essential. In patients with heart failure classified as NYHA class I-II, it should be used cautiously and is not recommended for class III-IV patients. When used with insulin or sulfonylureas, there is a risk of hypoglycemia, and dosage reduction of these agents may be necessary. Various adverse reactions may occur while taking this medication. The most common side effects include hypoglycemia, genital infections (such as vulvovaginitis in women), urinary tract infections, increased urination, and decreased fluid volume. Hypoglycemia, in particular, can occur more frequently when combined with insulin or sulfonylureas, so blood sugar levels should be monitored closely. Rarely, serious side effects such as ketoacidosis, pyelonephritis, rash, urticaria, angioedema, and perineal necrosis have been reported, so if any unusual symptoms arise, immediate consultation with a physician is warranted. This medication can induce severe ketoacidosis; therefore, if symptoms such as nausea, vomiting, abdominal pain, or difficulty breathing occur, prompt notification to healthcare providers is necessary. Elderly patients, particularly those over 75 years, have a higher risk of fluid loss, so careful monitoring is advised, and initiation is not recommended for those over 85 years. Patients at risk of fluid loss, such as those with hypotension or cardiovascular diseases, should monitor blood pressure and fluid status closely when taking this medication. This medication may affect driving or operating machinery, particularly in the presence of hypoglycemia risk. Pregnant women should avoid taking this medication, and breastfeeding women are advised to discontinue breastfeeding. The safety and efficacy of this medication have not been established in children under the age of 18. No specific toxic reactions have been reported in case of overdose; however, if overdose occurs, careful monitoring of the patient's condition and appropriate treatment should be undertaken. Finally, this medication should be kept out of the reach of children and should not be transferred to another container.

Side effects

  • Hypoglycemia
  • vulvovaginitis
  • balanitis
  • other genital infections
  • urinary tract infections
  • perineal necrosis
  • ketoacidosis
  • pruritus
  • rash
  • urticaria
Show 218 more
  • angioedema
  • decreased fluid volume
  • increased urination
  • difficulty urinating
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • colonic hemorrhage
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • adnexal-ovarian abscess
  • vestibular neuritis
  • acute pyelonephritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent narrowing
  • vascular stent thrombosis
  • ureteral stones
  • acute kidney injury
  • cervical inflammation
  • hyperglycemia
  • hyponatremia
  • diabetic foot
  • lumbar pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal venous occlusion
  • tractional retinal detachment
  • limb injuries
  • road traffic accidents
  • splenic injury
  • sternum fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • benign neoplasm of the ampulla of Vater
  • benign ovarian tumors
  • bladder cancer
  • gastric cancer
  • pancreatic carcinoma
  • colorectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • abdominal pain
  • dental caries
  • erosive gastritis
  • abdominal discomfort
  • dry mouth
  • gastroesophageal reflux disease
  • abdominal distension
  • anal bleeding
  • chronic gastritis
  • enteritis
  • bloating
  • gastric polyps
  • gingival swelling
  • passage of blood in stool
  • hemorrhoids
  • pancreatic cysts
  • rectal pain
  • toothache
  • upper respiratory tract infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • paronychia
  • tinea corporis
  • dental abscess
  • nasopharyngitis
  • positional dizziness
  • sensory loss
  • perceptual disturbances
  • amnesia
  • carotid artery stenosis
  • diabetic neuropathy
  • facial paralysis
  • memory disturbances
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • drowsiness
  • fatigue
  • peripheral edema
  • facial swelling
  • peripheral swelling
  • chills
  • strange sensations
  • swelling
  • pain
  • pain at the puncture site
  • weight gain
  • electrocardiogram abnormalities
  • decreased hemoglobin
  • increased hemoglobin
  • positive Helicobacter test
  • positive urine red blood cells
  • hematuria
  • overactive bladder
  • renal mass
  • urine retention
  • urinary tract pain
  • abnormal urination
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • obesity
  • acromegaly
  • dyslipidemia
  • dermoid cysts
  • seborrheic dermatitis
  • atopic dermatitis
  • circular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataracts
  • allergic conjunctivitis
  • blurred vision
  • corneal erosions
  • macular fibrosis
  • eye discomfort
  • eye congestion
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • nosebleeds
  • asthma
  • exertional dyspnea
  • moist cough
  • allergic rhinitis
  • cough
  • skin lacerations
  • contusions
  • rib fractures
  • concussion
  • corneal abrasion
  • falls
  • hand fractures
  • iliotibial band syndrome
  • open globe injury
  • pelvic fractures
  • palpitations
  • tachycardia
  • arteriosclerosis
  • diabetic vascular complications
  • peripheral arterial occlusive disease
  • anxiety
  • depression
  • sleep disorders
  • otalgia
  • positional vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodules
  • constipation
  • herpes zoster
  • chest discomfort
  • chest pain
  • weakness
  • weight loss
  • vulvar pruritus
  • genital pruritus
  • diabetic retinopathy
  • dry eyes
  • dyspnea
  • unstable angina
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain storage temperatures between 1 degree and 30 degrees Celsius to preserve its efficacy and safety.

Appearance and packaging

Appearance

Light yellow, round, biconvex film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.